Giuseppina D'Agostino

Title: Giuseppina D'Agostino: Innovator in Dendritic Cell Research

Introduction

Giuseppina D'Agostino is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of immunology, particularly in the development of methods for generating dendritic cells. Her innovative work has the potential to enhance therapeutic and prophylactic vaccination strategies for both animals and humans.

Latest Patents

D'Agostino holds a patent for a "Method for generating highly active human dendritic cells from peripheral blood mononuclear cells." This invention describes a process for deriving dendritic cells from mononuclear cells in culture. The method involves contacting type I IFN with the mononuclear cells, resulting in dendritic cells that can serve as cellular adjuvants in vaccination. The invention also includes pharmaceutical compositions, vaccines, and methods for treating pathologies associated with antigens in humans.

Career Highlights

Giuseppina D'Agostino is affiliated with the Istituto Superiore di Sanità, where she conducts her research. Her work has garnered attention for its innovative approach to immunotherapy and vaccine development. D'Agostino's research is crucial in advancing our understanding of dendritic cell biology and its applications in medicine.

Collaborations

Some of her notable coworkers include Tiziana Di Pucchio and Laura Santodonato. Their collaborative efforts contribute to the ongoing research and development in the field of immunology.

Conclusion

Giuseppina D'Agostino's contributions to dendritic cell research exemplify the impact of innovative thinking in the medical field. Her patent and ongoing work hold promise for improving vaccination strategies and therapeutic interventions.